Breaking News Headlines Today

News from ophthalmologytimes.com

Your destination for news from ophthalmologytimes.com. See how ophthalmologytimes.com’s media bias impacts the breaking news stories of today.

Ground News has come across 316 headlines reported on by ophthalmologytimes.com during the past 3 months.

We’ve assigned a media bias rating of unknown to ophthalmologytimes.com. You can read more about our methodology here.

ophthalmologytimes.com’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about ophthalmologytimes.com

Where is ophthalmologytimes.com located?ophthalmologytimes.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top ophthalmologytimes.com News

Innovation

Part 7: Looking back at 50 years of innovation in ophthalmology

To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ophthalmology over the past five decades.Read Article

AMD · United States

Annexon completes enrollment in phase 3 ARCHER II trial of vonaprument for geographic atrophy

Vonaprument has been granted Fast Track designation from the US Food and Drug Administration.See the Story

AMD · United States

NEW DAY trial of ILUVIEN for DME does not meet primary endpoint, post-hoc analysis suggests potential benefits

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.Read Article

Q&A: Natalie Afshari, MD, FACS, championing on-label pediatric IOLs: turning advocacy into access

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.Maryland · Maryland Read Article

Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence

At the CCOI-Stanford Summit, Goldberg calls for collaborative trial models that could redefine efficiency and standardization in ophthalmology research.Stanford · Stanford Read Article

Part 5: Looking back at 50 years of innovation in ophthalmology

To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ophthalmology over the past five decades.Innovation Read Article

First US patient receives Eyetronic glaucoma treatment at Glaucoma Center of San Francisco

Eyetronic is a noninvasive treatment for glaucoma that provides external neural stimulation to the optic nerve of patients.San Francisco, California · San Francisco Read Article

Role of mucormycosis infection on vision in diabetic patient

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.See the Story

News from ophthalmologytimes.com

News from ophthalmologytimes.com

Information about ophthalmologytimes.com

Media Bias Ratings

Factuality

Ownership

Top ophthalmologytimes.com News

Part 7: Looking back at 50 years of innovation in ophthalmology

Annexon completes enrollment in phase 3 ARCHER II trial of vonaprument for geographic atrophy

Kiora Pharmaceuticals Secures US Patent for KIO-104

Scuba divers and surfers face dual light exposure that may accelerate AMD

Aldeyra Therapeutics receives orphan designation for ADX-2191 from EMA

NEW DAY trial of ILUVIEN for DME does not meet primary endpoint, post-hoc analysis suggests potential benefits

Q&A: Natalie Afshari, MD, FACS, championing on-label pediatric IOLs: turning advocacy into access

Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence

Part 5: Looking back at 50 years of innovation in ophthalmology

First US patient receives Eyetronic glaucoma treatment at Glaucoma Center of San Francisco

Role of mucormycosis infection on vision in diabetic patient

Similar News Topics

Topics Most Covered by ophthalmologytimes.com

Sources Covering Similar Topics

Breaking News Topics Related to ophthalmologytimes.com

Information about ophthalmologytimes.com

Media Bias Ratings

Factuality

Ownership

Scuba divers and surfers face dual light exposure that may accelerate AMD

Aldeyra Therapeutics receives orphan designation for ADX-2191 from EMA

NEW DAY trial of ILUVIEN for DME does not meet primary endpoint, post-hoc analysis suggests potential benefits

Q&A: Natalie Afshari, MD, FACS, championing on-label pediatric IOLs: turning advocacy into access

Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence

Part 5: Looking back at 50 years of innovation in ophthalmology

First US patient receives Eyetronic glaucoma treatment at Glaucoma Center of San Francisco

Role of mucormycosis infection on vision in diabetic patient